Why the study?
Does L-arginine supplementation alter protein expression in coronary venular endothelial cells?
Does L-arginine supplementation alter protein expression in coronary venular endothelial cells?
Physiological levels of L-arginine alter the expression of key structural and regulatory proteins in coronary venular endothelial cells, potentially explaining its beneficial effects on the circulatory system.
Answers are grounded in this paper and cite their sources.
L-arginine modulates endothelial proteins in vitro; hypothesis-generating for coronary effects in vivo.
L-Arginine is a conditionally essential amino acid for humans and plays an important role in the regulation of cardiovascular function and antioxidative defense. Previous studies have focused on the important role of L-arginine as a physiological precursor in the generation of nitric oxide and polyamines in endothelial cells (cells that line the interior surface of blood vessels). Because of the rapid development of high-throughput proteomics technology, there is now growing interest in studying roles for L-arginine in modulating endothelial-cell protein expression. Of particular interest, recent proteomics analysis has shown that treatment of coronary venular endothelial cells with a physiological level of L-arginine (e.g., 0.1 mM) increases expression of structural proteins (vimentin and tropomyosin) and cytochrome bc1 complex iii-chain A, while decreasing expression of stress-related proteins (PDZ domain containing-3), in these cells. These findings aid in elucidating the mechanisms responsible for the beneficial effect of physiological levels of L-arginine on the circulatory system.
No takes yet. Share an insight, caveat, or question.
Junjun Wang (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: